2021 ESC Guidelines on cardiovascular disease prevention in clinical practiceFrank L.J. Visseren|European Heart Journal|2021Cited by 6.1k
Simvastatin with or without Ezetimibe in Familial HypercholesterolemiaJohn J.P. Kastelein, Eric de Groot, Fatima Akdim et al.|New England Journal of Medicine|2008Cited by 1.2k
Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention PopulationLotte Kaasenbrood, Frank L.J. Visseren, S. Matthijs Boekholdt et al.|Circulation|2016Cited by 275
Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk scoreJohannes A N Dorresteijn, Frank L.J. Visseren, Annemarie M.J. Wassink et al.|Heart|2013Cited by 265
Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetesShahnam Sharif, Hendrik M. Nathoe, Yolanda van der Graaf et al.|Cardiovascular Diabetology|2021Cited by 204